NN, Inc. To Sell Life Sciences Unit For $825 Mln - Quick Facts

(RTTNews) - NN, Inc. (NNBR) entered an agreement under which the company's Life Sciences unit will be purchased by affiliates of American Securities LLC. The Life Sciences division will be purchased for $825 million, including $755 million in cash payable at closing of the transaction and an additional $70 million earnout payable in cash based on the 2022 performance of the Life Sciences division. The sale follows a comprehensive review of NN's businesses initiated by the company in November 2019.

NN expects to use the estimated $700 million in net proceeds from the sale to further pay down its debt and strengthen its balance sheet.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More